denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Program: Special-Interest Sessions
Session: ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Adult, Clinical Practice (Health Services and Quality), Elderly, Clinical Research, Health outcomes research, Bioinformatics, Patient-reported outcomes, Diseases, Real-world evidence, Registries, Lymphoid Malignancies, Technology and Procedures, Study Population, Human, Measurable Residual Disease
Session: ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
Hematology Disease Topics & Pathways:
Research, Artificial intelligence (AI), Adult, Clinical Practice (Health Services and Quality), Elderly, Clinical Research, Health outcomes research, Bioinformatics, Patient-reported outcomes, Diseases, Real-world evidence, Registries, Lymphoid Malignancies, Technology and Procedures, Study Population, Human, Measurable Residual Disease
Saturday, December 7, 2024, 4:00 PM-5:30 PM
Disclosures: Hansen: Karyopharm: Consultancy, Research Funding; Pfizer: Consultancy; Janssen: Consultancy; BMS: Consultancy, Research Funding.
See more of: ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation
See more of: Special-Interest Sessions
See more of: Special-Interest Sessions
<< Previous Presentation
|
Next Presentation